76.99 USD
0.000.00%
盘后 77.00 0.00%
2026-08-26
市值
$1.94B
市盈率
—
EPS
-4.54
股息率
—
52 周区间
10.11 – 77.20
成交量
1.39M
Beta
2.64
目标价
73.80
52W 低 10.1152W 高 77.20
价格走势
公司简介
Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for autoimmune and autoimmune-related diseases. The company offers products, such as its lead product candidate FB102, a proprietary molecule with applications for celiac disease, vitiligo, and alopecia areata; and services, including the clinical development and management of its Phase 2 clinical trials. Forte Biosciences, Inc. was incorporated in 2007 and is based in Dallas, Texas. As of August 27, 2026, Forte Biosciences, Inc. operates as a subsidiary ...